Financhill
Buy
75

BLGV.CX Quote, Financials, Valuation and Earnings

Last price:
$0.07
Seasonality move :
-7.1%
Day range:
$0.07 - $0.08
52-week range:
$0.01 - $0.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
62.8K
Avg. volume:
288.5K
1-year change:
250%
Market cap:
$4.7M
Revenue:
-$638.4K
EPS (TTM):
-$0.04

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BLGV.CX
Belgravia Hartford Capital
-- -- -- -- --
GPK.CX
Grand Peak Capital
-- -- -- -- --
IDK.CX
ThreeD Capital
-- -- -- -- --
MBAI.CX
MedBright AI Investments
-- -- -- -- --
POLE.CX
Polaris Northstar Capital
-- -- -- -- --
QCA.CX
Quinsam Capital
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BLGV.CX
Belgravia Hartford Capital
$0.07 -- $4.7M -- $0.00 0% --
GPK.CX
Grand Peak Capital
$0.1000 -- $15.9M -- $0.00 0% 27.04x
IDK.CX
ThreeD Capital
$0.20 -- $11.3M 3.44x $0.00 0% 1.44x
MBAI.CX
MedBright AI Investments
$0.07 -- $7.2M -- $0.00 0% --
POLE.CX
Polaris Northstar Capital
$0.04 -- $2.3M -- $0.00 0% --
QCA.CX
Quinsam Capital
$0.05 -- $4.2M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BLGV.CX
Belgravia Hartford Capital
-- -5.688 -- 0.53x
GPK.CX
Grand Peak Capital
-- 38.552 -- 13.89x
IDK.CX
ThreeD Capital
0.93% 1.281 3.1% 1.45x
MBAI.CX
MedBright AI Investments
-- -0.102 -- --
POLE.CX
Polaris Northstar Capital
-- 0.000 -- --
QCA.CX
Quinsam Capital
-- -0.559 -- 27.94x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BLGV.CX
Belgravia Hartford Capital
-$76.5K -$349.3K -2254.18% -2254.18% -4981.18% -$350.8K
GPK.CX
Grand Peak Capital
$222.6K $180.3K -39.07% -39.07% 80.99% -$96.5K
IDK.CX
ThreeD Capital
-- -- -8.47% -8.56% -4693.13% -$737.7K
MBAI.CX
MedBright AI Investments
-- -$246K -- -- -- -$186.5K
POLE.CX
Polaris Northstar Capital
-- -- -- -- -- --
QCA.CX
Quinsam Capital
-$576.3K $1.2M -2.62% -2.62% -234.02% -$517.9K

Belgravia Hartford Capital vs. Competitors

  • Which has Higher Returns BLGV.CX or GPK.CX?

    Grand Peak Capital has a net margin of -4964.55% compared to Belgravia Hartford Capital's net margin of 81.22%. Belgravia Hartford Capital's return on equity of -2254.18% beat Grand Peak Capital's return on equity of -39.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    BLGV.CX
    Belgravia Hartford Capital
    -1091.02% -$0.01 -$300K
    GPK.CX
    Grand Peak Capital
    68.21% $0.00 $3.2M
  • What do Analysts Say About BLGV.CX or GPK.CX?

    Belgravia Hartford Capital has a consensus price target of --, signalling downside risk potential of --. On the other hand Grand Peak Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that Belgravia Hartford Capital has higher upside potential than Grand Peak Capital, analysts believe Belgravia Hartford Capital is more attractive than Grand Peak Capital.

    Company Buy Ratings Hold Ratings Sell Ratings
    BLGV.CX
    Belgravia Hartford Capital
    0 0 0
    GPK.CX
    Grand Peak Capital
    0 0 0
  • Is BLGV.CX or GPK.CX More Risky?

    Belgravia Hartford Capital has a beta of 1.830, which suggesting that the stock is 82.967% more volatile than S&P 500. In comparison Grand Peak Capital has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.13%.

  • Which is a Better Dividend Stock BLGV.CX or GPK.CX?

    Belgravia Hartford Capital has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grand Peak Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Belgravia Hartford Capital pays -- of its earnings as a dividend. Grand Peak Capital pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BLGV.CX or GPK.CX?

    Belgravia Hartford Capital quarterly revenues are $7K, which are smaller than Grand Peak Capital quarterly revenues of $222.6K. Belgravia Hartford Capital's net income of -$348.1K is lower than Grand Peak Capital's net income of $180.8K. Notably, Belgravia Hartford Capital's price-to-earnings ratio is -- while Grand Peak Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Belgravia Hartford Capital is -- versus 27.04x for Grand Peak Capital. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BLGV.CX
    Belgravia Hartford Capital
    -- -- $7K -$348.1K
    GPK.CX
    Grand Peak Capital
    27.04x -- $222.6K $180.8K
  • Which has Higher Returns BLGV.CX or IDK.CX?

    ThreeD Capital has a net margin of -4964.55% compared to Belgravia Hartford Capital's net margin of -5609.87%. Belgravia Hartford Capital's return on equity of -2254.18% beat ThreeD Capital's return on equity of -8.56%.

    Company Gross Margin Earnings Per Share Invested Capital
    BLGV.CX
    Belgravia Hartford Capital
    -1091.02% -$0.01 -$300K
    IDK.CX
    ThreeD Capital
    -- -$0.02 $45.5M
  • What do Analysts Say About BLGV.CX or IDK.CX?

    Belgravia Hartford Capital has a consensus price target of --, signalling downside risk potential of --. On the other hand ThreeD Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that Belgravia Hartford Capital has higher upside potential than ThreeD Capital, analysts believe Belgravia Hartford Capital is more attractive than ThreeD Capital.

    Company Buy Ratings Hold Ratings Sell Ratings
    BLGV.CX
    Belgravia Hartford Capital
    0 0 0
    IDK.CX
    ThreeD Capital
    0 0 0
  • Is BLGV.CX or IDK.CX More Risky?

    Belgravia Hartford Capital has a beta of 1.830, which suggesting that the stock is 82.967% more volatile than S&P 500. In comparison ThreeD Capital has a beta of 1.492, suggesting its more volatile than the S&P 500 by 49.18%.

  • Which is a Better Dividend Stock BLGV.CX or IDK.CX?

    Belgravia Hartford Capital has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ThreeD Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Belgravia Hartford Capital pays -- of its earnings as a dividend. ThreeD Capital pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BLGV.CX or IDK.CX?

    Belgravia Hartford Capital quarterly revenues are $7K, which are smaller than ThreeD Capital quarterly revenues of $19.6K. Belgravia Hartford Capital's net income of -$348.1K is higher than ThreeD Capital's net income of -$1.1M. Notably, Belgravia Hartford Capital's price-to-earnings ratio is -- while ThreeD Capital's PE ratio is 3.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Belgravia Hartford Capital is -- versus 1.44x for ThreeD Capital. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BLGV.CX
    Belgravia Hartford Capital
    -- -- $7K -$348.1K
    IDK.CX
    ThreeD Capital
    1.44x 3.44x $19.6K -$1.1M
  • Which has Higher Returns BLGV.CX or MBAI.CX?

    MedBright AI Investments has a net margin of -4964.55% compared to Belgravia Hartford Capital's net margin of --. Belgravia Hartford Capital's return on equity of -2254.18% beat MedBright AI Investments's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BLGV.CX
    Belgravia Hartford Capital
    -1091.02% -$0.01 -$300K
    MBAI.CX
    MedBright AI Investments
    -- -$0.00 --
  • What do Analysts Say About BLGV.CX or MBAI.CX?

    Belgravia Hartford Capital has a consensus price target of --, signalling downside risk potential of --. On the other hand MedBright AI Investments has an analysts' consensus of -- which suggests that it could fall by --. Given that Belgravia Hartford Capital has higher upside potential than MedBright AI Investments, analysts believe Belgravia Hartford Capital is more attractive than MedBright AI Investments.

    Company Buy Ratings Hold Ratings Sell Ratings
    BLGV.CX
    Belgravia Hartford Capital
    0 0 0
    MBAI.CX
    MedBright AI Investments
    0 0 0
  • Is BLGV.CX or MBAI.CX More Risky?

    Belgravia Hartford Capital has a beta of 1.830, which suggesting that the stock is 82.967% more volatile than S&P 500. In comparison MedBright AI Investments has a beta of -0.066, suggesting its less volatile than the S&P 500 by 106.645%.

  • Which is a Better Dividend Stock BLGV.CX or MBAI.CX?

    Belgravia Hartford Capital has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. MedBright AI Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Belgravia Hartford Capital pays -- of its earnings as a dividend. MedBright AI Investments pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BLGV.CX or MBAI.CX?

    Belgravia Hartford Capital quarterly revenues are $7K, which are larger than MedBright AI Investments quarterly revenues of --. Belgravia Hartford Capital's net income of -$348.1K is lower than MedBright AI Investments's net income of -$303.3K. Notably, Belgravia Hartford Capital's price-to-earnings ratio is -- while MedBright AI Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Belgravia Hartford Capital is -- versus -- for MedBright AI Investments. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BLGV.CX
    Belgravia Hartford Capital
    -- -- $7K -$348.1K
    MBAI.CX
    MedBright AI Investments
    -- -- -- -$303.3K
  • Which has Higher Returns BLGV.CX or POLE.CX?

    Polaris Northstar Capital has a net margin of -4964.55% compared to Belgravia Hartford Capital's net margin of --. Belgravia Hartford Capital's return on equity of -2254.18% beat Polaris Northstar Capital's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BLGV.CX
    Belgravia Hartford Capital
    -1091.02% -$0.01 -$300K
    POLE.CX
    Polaris Northstar Capital
    -- -- --
  • What do Analysts Say About BLGV.CX or POLE.CX?

    Belgravia Hartford Capital has a consensus price target of --, signalling downside risk potential of --. On the other hand Polaris Northstar Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that Belgravia Hartford Capital has higher upside potential than Polaris Northstar Capital, analysts believe Belgravia Hartford Capital is more attractive than Polaris Northstar Capital.

    Company Buy Ratings Hold Ratings Sell Ratings
    BLGV.CX
    Belgravia Hartford Capital
    0 0 0
    POLE.CX
    Polaris Northstar Capital
    0 0 0
  • Is BLGV.CX or POLE.CX More Risky?

    Belgravia Hartford Capital has a beta of 1.830, which suggesting that the stock is 82.967% more volatile than S&P 500. In comparison Polaris Northstar Capital has a beta of 8.299, suggesting its more volatile than the S&P 500 by 729.945%.

  • Which is a Better Dividend Stock BLGV.CX or POLE.CX?

    Belgravia Hartford Capital has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Polaris Northstar Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Belgravia Hartford Capital pays -- of its earnings as a dividend. Polaris Northstar Capital pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BLGV.CX or POLE.CX?

    Belgravia Hartford Capital quarterly revenues are $7K, which are larger than Polaris Northstar Capital quarterly revenues of --. Belgravia Hartford Capital's net income of -$348.1K is higher than Polaris Northstar Capital's net income of --. Notably, Belgravia Hartford Capital's price-to-earnings ratio is -- while Polaris Northstar Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Belgravia Hartford Capital is -- versus -- for Polaris Northstar Capital. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BLGV.CX
    Belgravia Hartford Capital
    -- -- $7K -$348.1K
    POLE.CX
    Polaris Northstar Capital
    -- -- -- --
  • Which has Higher Returns BLGV.CX or QCA.CX?

    Quinsam Capital has a net margin of -4964.55% compared to Belgravia Hartford Capital's net margin of -234.02%. Belgravia Hartford Capital's return on equity of -2254.18% beat Quinsam Capital's return on equity of -2.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    BLGV.CX
    Belgravia Hartford Capital
    -1091.02% -$0.01 -$300K
    QCA.CX
    Quinsam Capital
    85.34% $0.01 $13.4M
  • What do Analysts Say About BLGV.CX or QCA.CX?

    Belgravia Hartford Capital has a consensus price target of --, signalling downside risk potential of --. On the other hand Quinsam Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that Belgravia Hartford Capital has higher upside potential than Quinsam Capital, analysts believe Belgravia Hartford Capital is more attractive than Quinsam Capital.

    Company Buy Ratings Hold Ratings Sell Ratings
    BLGV.CX
    Belgravia Hartford Capital
    0 0 0
    QCA.CX
    Quinsam Capital
    0 0 0
  • Is BLGV.CX or QCA.CX More Risky?

    Belgravia Hartford Capital has a beta of 1.830, which suggesting that the stock is 82.967% more volatile than S&P 500. In comparison Quinsam Capital has a beta of 1.172, suggesting its more volatile than the S&P 500 by 17.197%.

  • Which is a Better Dividend Stock BLGV.CX or QCA.CX?

    Belgravia Hartford Capital has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quinsam Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Belgravia Hartford Capital pays -- of its earnings as a dividend. Quinsam Capital pays out -6.06% of its earnings as a dividend.

  • Which has Better Financial Ratios BLGV.CX or QCA.CX?

    Belgravia Hartford Capital quarterly revenues are $7K, which are larger than Quinsam Capital quarterly revenues of -$517.6K. Belgravia Hartford Capital's net income of -$348.1K is lower than Quinsam Capital's net income of $1.2M. Notably, Belgravia Hartford Capital's price-to-earnings ratio is -- while Quinsam Capital's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Belgravia Hartford Capital is -- versus -- for Quinsam Capital. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BLGV.CX
    Belgravia Hartford Capital
    -- -- $7K -$348.1K
    QCA.CX
    Quinsam Capital
    -- -- -$517.6K $1.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 22.25% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 20.59% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 19.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock